Overview of the blood bank refrigerators market in the US
Technavio’s market research analyst predicts the blood bank refrigerators market in the US to grow steadily at a CAGR of around 6% by 2021. One of the primary drivers for this market is the rise in the number of blood banks in the region. In modern healthcare system, an increase in life expectancy, and a higher incidence of numerous diseases, has created the need for blood and blood derivative. This rise in the demand for blood has in fluxed a requirement for proper preservation and trackable storage solutions such as blood bank refrigerators. Also, new treatments and practices, along with increased sophistication of surgical and medical procedures, have intensified the need for availability of blood on standby. The US government and private organizations have become proactive in setting up blood banks to cater to the growing demand for blood and blood derivatives. The growth in the number of blood banks in the US will offer expanded opportunities for blood bank refrigerator solution providers in the country over the next few years.
One of the latest trends gaining traction in this market is the development in temperature monitoring systems. Temperature monitoring systems has been a very critical aspect in blood bank refrigerator offerings, as blood storage efficiency is subject to a range of variables such as power failure, the frequency of inventory load, door openings, and changes in room temperature. This has created an opportunity for services like real-time information, data management, and remote access to data through mobile and other devices. External
Overview of the global homogenizers market
Technavio’s market research analyst predicts the global homogenizers market to grow steadily at a CAGR of above 5% by 2021. One of the primary growth drivers for this market is the exponential growth of the pharmaceutical industry. The global pharmaceutical industry has been driven by the demand for innovative pharmaceutical products, which is in step with the growth in the world’s population. With the trending patterns like global warming, environmental pollution, and erratic eating habits of people, large sections of the population are likely to suffer from health problems such as heart diseases, diabetes, and cancer. As per a WHO forecast, non-communicable diseases will be one of the major causes of fatalities by 2020. Moreover, many developing countries are also improving access to healthcare and hosting mobile clinics for rural communities. The growing pharmaceutical industry and increasing demand for prescribed drugs are expected to drive the demand for homogenizers during the forecast period.
In terms of geography, the Americas accounted for the maximum market share during 2016. The major factor responsible for this dominance is the presence of large fast-moving consumer goods (FMCG) and pharmaceutical companies in the region. The homogenizer market in the Americas is dominated by North America, followed by South America. Also, factors like easy access, a satisfactory amount of government funding and investments, and rise in the number of collaborations and acquisitions between companies that deal with homogenizers are further contributing to the growth of the homogenizer market in the region.
Overview of the microarray market
Extensive research carried out by the analysts at Technavio has shown that the global microarray market is expected to witness tremendous growth and will post a staggering CAGR of more than 14% during the forecast period. One of the primary factors driving this market’s growth is the emergence of microarrays in genomics and proteomics. These technologies are used for genotyping, mutation screening, protein interaction studies, and gene expression analysis. For instance, DNA microarray technology is used to develop new gene expression patterns across gene families, expand gene family size, and discover new categories of genes. Moreover, microarray technology can also be used to disease diagnosis, which will eventually aid in determining better treatment strategies. Although microarray is an expensive technology, its extensive applications in the healthcare sector due to its portability, rapid assay times, and fewer sample requirements will lead to its augmented adoption in the future.
In terms of geographical regions, the Americas was the highest revenue-contributing region in the global microarray market during 2015. The market will continue to be led by the Americas over the next four years due to an increase in research investments made by several biotechnology and pharmaceutical companies to develop targeted therapeutics using microarray technologies, such as tissue, DNA, and protein microarray solutions. Also, the region is home to several big pharmaceutical companies which conduct gene testing using various microarray technologies, including DNA microarray, LOC, protein microarray, and tissue microarray. North America will be the key revenue contributor in the region owing to a
Overview of the global chromatography market
According to the market research analysts at Technavio, the global chromatography market is anticipated to witness steady growth and will post a moderate CAGR of more than 5% during the forecast period. The rapid automation of sample handling processes in the laboratories and research facilities is one of the primary factors driving this market’s growth. Sample handling equipment replace the need for manual manipulation and helps streamline experiments. Laboratory automation is widely adopted in the fields of biology and chemistry, particularly in applications such as high-throughput screening, automated clinical and analytical testing, diagnostics, combinatorial chemistry, and large-scale biorepositories. Automation of sampling handling processes not only reduces the chances of error but also allows greater control and precision of the quantity of the sample or solution to be used. Moreover, the integration of automated systems in the sample handling, separation, and purification processes in chromatography has led to the introduction of several new instruments and accessories that can work in tandem with chromatography instruments.
In terms of geography, the Americas led the market and will continue to dominate the market during the forecast period. The chromatography market in the Americas is led by the US and Canada. The growth of this market in the region is attributed to the increasing adoption of highly advanced chromatic techniques by the pharmaceutical and
Overview of the breath analyzers market
Extensive research carried out by the analysts at Technavio has shown that the global breath analyzers market will witness exponential growth and post a tremendous CAGR of more than 25% over the forecast period. The increasing demand for breath analyzers has led to the manufacturers introducing several innovations in the product, which is expected to have a positive impact on this market’s growth in the coming years. The technology used in breath analyzers has been around for decades, whether it is infrared, semiconductor, or fuel cell sensors. The challenge to reduce the size and processing time of these devices to a minimum, without compromising on the accuracy of the sensor, was met by the evolution of integrated circuits and the miniaturization of electronics. Moreover, some of these breath analyzers can also be connected to a smartphone via microUSB or Bluetooth, allowing the users to track BAC and health conditions using an application on their smartphones. The reduction in size and introduction of nifty features in breath analyzers will lead to their augmented adoption over the next four years.
In terms of geography, the Americas led the market and is likely to account for over 47% of the revenue market shares by 2020. Factors such as stringent road safety regulations relatively stronger infrastructure of law enforcement agencies will drive the market in this region. The US was the highest revenue contributor in the region as it is home to some of the biggest companies in this market such as Lifeloc Technologies, BACtrack, Quest Products, Intoximeter, and Akers Biosciences, thereby giving consumers access to a wider range of products.
Competitive landscape and key vendors
Global market overview for DNA microarrays
According to the analysts at Technavio, the global market for DNA microarrays will experience promising growth during the estimated period and will be affected by factors like the rising popularity of personalized medicines. During the forecast period, it is estimated that the popularity of DNA microarray technology will increase significantly as it helps in the early detection of diseases and selection of accurate treatment methods, which reduces mortality rates. This technology also enables researchers to analyze critical biological complications such as genomic variations and the nature of inherited syndromes that cause cardiovascular diseases and cancers. The ability of this technology to perform gene profiling of patients, understand the risk of clinical outcomes, and study an individual's response to specific drugs, will result in this market’s impressive CAGR of over 15% by 2020.
In terms of geography, the Americas will be the largest market for DNA microarrays and will continue its market dominance until the end of 2020. Much of this market’s growth in the Americas can be attributed to the recent increase in the number of age-related chronic diseases, which will, in turn, necessitate the utilization of technologies such as DNA microarrays for testing and development of new drugs. Additionally, the recent increase in investments by biotechnology and pharmaceutical companies to develop targeted therapeutics using DNA microarray solutions will result in this region’s market dominance during the estimated period.
Competitive landscape and key vendors
The global DNA microarray market is extremely